Dr. Walker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5565 Carpinteria Ave
Suite 2
Carpinteria, CA 93013Phone+1 805-745-1013Fax+1 805-566-0319
Education & Training
- National Institutes of Health Clinical CenterResidency, Dermatology, 1993 - 1997
- University of Iowa Hospitals and ClinicsResidency, Dermatology, 1991 - 1993
- University of MinnesotaInternship, Internal Medicine, 1990 - 1991
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1990
Certifications & Licensure
- CA State Medical License 1998 - 2026
- IA State Medical License 1991 - 1999
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Publications & Presentations
PubMed
- 24 citationsA phase 1 pharmacokinetic study of ATX-101: serum lipids and adipokines following synthetic deoxycholic acid injectionsPatricia Walker, Daniel R. Lee
Journal of Cosmetic Dermatology. 2015-03-01 - 30 citationsNatrelle saline-filled breast implants: a prospective 10-year study.Patricia S. Walker, Beth Walls, Diane K. Murphy
Aesthetic Surgery Journal. 2009-01-01 - 86 citationsGenetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.Patricia S. Walker, Tanya Scharton-Kersten, Edgar D. Rowton, Ulrich R. Hengge, Anne Bouloc
Human Gene Therapy. 1998-09-01
Press Mentions
- Brickell Biotech Announces Positive Phase 2b Study Results for BBI-4000 (Sofpironium Bromide) in Subjects with Primary Axillary HyperhidrosisOctober 24th, 2017
- Newly Published Data Reveal That Hyperhidrosis (Excessive Sweating) Is More Prevalent, Severe and Socially Debilitating Than Previously ReportedOctober 19th, 2016
- BBI-4000 (Sofpironium Bromide) Demonstrates Promising Potential as a Safe and Effective First-Line Treatment for Excessive Underarm SweatingMarch 7th, 2016
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: